Monday, February 17, 2025
2/17/2025
PROJECT SUMMARY Substance abuse disorders including opioid dependence are characterized by brain oxidative stress and neu- roinflammation. In addition to dopamine autooxidation, chronic drug consumption increases the expression of pro-oxidant enzymes such as NADPH-oxidase (NOX), leading to excessive production of reactive oxygen spe- cies (ROS) primarily in the form hydrogen peroxide (H2O2). Endogenous H2O2 can transiently and/or irreversibly oxidize cysteinyl residues depending upon its concentration and duration of exposure. In proteins, H2O2 reacts with redox-sensitive cysteine thiols to form sulfenic acid (Cys-SOH). Cysteine S-sulfenation has emerged as a major post-translational modification that exerts significant effects on protein function, analogous to phosphory- lation. A small but compelling literature suggests that changes in cysteine redox state affect mu opioid receptor (MOR) function, as thiol alkylation, site-directed mutagenesis, and redox-modulating agents can alter ligand binding and downstream signaling events. In addition to structural and regulatory roles, oxidation of the cysteine thiol blocks the reaction of this residue with a,b-unsaturated carbonyls and alkyl halides, significantly limiting the utility of conventional electrophile-fragment screening as a tool for covalent ligand discovery. To address this issue, we have recently developed a strategy that employs nucleophilic covalent fragments to target S-sulfenated (oxidized) cysteines. These sulfenic acid-reactive activity-based protein profiling (ABPP) probes have been cou- pled with state-of-the-art quantitative proteomics to identify S-sulfenated cysteines in human cells, which presage the development of covalent fragments therapeutically targeting redox-active cysteines. Here, the following Spe- cific Aims are proposed: 1) Increase the size and structural diversity of our nucleophile-fragment libraries; 2) Map cysteine redox reactivity changes and S-sulfenated (oxidized) cysteine ligandability in differentiated mature SH- SY5Y neurons that are unstimulated (control) or treated with morphine agonist (stimulated). These studies are rationalized based on proof-of-concept experiments which demonstrate that unique ligandable sites are identified when fragments are functionalized with nucleophilic reactive groups that react with S-sulfenated (oxidized) cys- teine residues. Deliverables from these studies are a novel chemoproteomic method, chemical matter that can be mined as a source of small-molecule probes and as starting points for drug discovery.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).